Moderna Refused China Request to Reveal Vaccine Technology
Moderna has refused to hand over to China the core intellectual property behind the development of its COVID-19 vaccine, leading to a collapse in negotiations on its sale there, the Financial Times reported on Saturday, citing people familiar with the matter.
Reuters Health Information
source https://www.medscape.com/viewarticle/981745?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/981745?src=rss
Comments
Post a Comment